Related Experiment Video
Updated: Jun 22, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Aryl hydrocarbon receptor inhibition downregulates the TGF-beta/Smad pathway in human glioblastoma cells
D Gramatzki1, G Pantazis, J Schittenhelm
1Laboratory of Molecular Neuro-Oncology, Department of General Neurology and Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany.
Abstract:
The dioxin/aryl hydrocarbon receptor (AhR) is a transcription factor, which has been attributed a role in human cancerogenesis, cell cycle progression and transforming growth factor-beta (TGF-beta) signaling. As TGF-beta is an important mediator of the malignant phenotype of human gliomas, we studied AhR expression and function in glioma cells. AhR was not only expressed in glioma cells in vitro, but was also detected in human gliomas in vivo by immunohistochemistry, with a predominantly nuclear staining in glioblastomas. The AhR agonist, 3-methylcholanthrene, induced AhR nuclear translocation and upregulated mRNA levels of the AhR target gene, cytochrome P450 1A1 (CYP1A1). Conversely, pharmacological inhibition of AhR using the novel AhR antagonist, CH-223191, or AhR gene silencing using small interfering RNA showed that constitutive AhR activity positively controls TGF-beta1, TGF-beta2 and latent TGF-beta-binding protein-1 protein levels in malignant glioma cells. Moreover, antagonism of AhR reduced clonogenic survival and invasiveness of glioma cells. In contrast, AhR regulates TGF-beta signaling negatively in non-neoplastic astrocytes. Thus, the pathogenesis of glioma formation may involve altered AhR regulation of the TGF-beta/Smad pathway, and AhR may represent a promising target for the treatment of human malignant gliomas and other diseases associated with pathological TGF-beta activity.
Insights
The aryl hydrocarbon receptor (AhR) promotes malignant glioma growth by upregulating transforming growth factor-beta (TGF-beta) signaling. Inhibiting AhR reduces glioma cell survival and invasiveness, suggesting AhR as a potential therapeutic target.
Area of Science:
- Molecular biology
- Oncology
- Cell signaling
Background:
- The aryl hydrocarbon receptor (AhR) is a transcription factor implicated in cancerogenesis and transforming growth factor-beta (TGF-beta) signaling.
- TGF-beta is a key mediator of the malignant phenotype in human gliomas.
Purpose of the Study:
- To investigate the expression and function of AhR in glioma cells.
- To determine the role of AhR in TGF-beta signaling within gliomas.
- To evaluate AhR as a potential therapeutic target for malignant gliomas.
Main Methods:
- Immunohistochemistry to detect AhR expression in human gliomas.
- Treatment with an AhR agonist (3-methylcholanthrene) and antagonist (CH-223191).
- AhR gene silencing using small interfering RNA.
- Analysis of TGF-beta1, TGF-beta2, latent TGF-beta-binding protein-1, and CYP1A1 mRNA and protein levels.
- Assessment of glioma cell clonogenic survival and invasiveness.
Main Results:
- AhR was expressed in glioma cells in vitro and detected in vivo, with nuclear localization in glioblastomas.
- AhR activation upregulated its target gene CYP1A1.
- AhR inhibition or silencing reduced TGF-beta1, TGF-beta2, and latent TGF-beta-binding protein-1 levels in malignant glioma cells.
- AhR antagonism decreased glioma cell clonogenic survival and invasiveness.
- AhR negatively regulated TGF-beta signaling in non-neoplastic astrocytes.
Conclusions:
- Altered AhR regulation of the TGF-beta/Smad pathway is involved in glioma pathogenesis.
- AhR antagonism shows potential for treating malignant gliomas.
- AhR may be a therapeutic target for diseases involving pathological TGF-beta activity.
Related Concept Videos
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Hedgehog Signaling Pathway
